Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Understanding the best financial practices for retirement is key. Learn about the top strategies to ensure a comfortable retirement.
19,657 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A joint regulatory move reclassifies crypto assets into five categories, easing KYC-heavy requirements for developers...
Alibaba shares slid about 7% after quarterly results, underscoring a push into AI and cloud infrastructure. Investors...
Hecla Mining stock plunged from its peak as metal prices and costs shifted. This guide breaks down the key factors, w...
A central Ohio commuter planning 50,000 extra miles over five years weighs the new-car advantage as Clark Howard’s ve...
A data center hardware maker saw a dramatic stock drop this week amid regulatory and supply chain concerns. This guid...
A respected technical analyst outlines a Fibonacci-driven path that could push XRP to $27, igniting debate as regulat...
Investors are increasingly adding blue-chip art to mainstream portfolios to diversify beyond stocks and bonds. Fracti...
AI ambitions collide with power limits. This article explains the gigawatt pivot, why it matters for investors, and w...
A seasoned fund boosted its stake in ZoomInfo, revealing a confident bet on GTM's growth story. This article explains...
Tokenized commodities are driving a record surge in HIP-3 open interest, led by Trade.xyz. The market shows a shift f...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...